483
Sajjad A. Sabir, M.D.FDA 483 - Sajjad A. Sabir, M.D. - May 23, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Sajjad A. Sabir, M.D., a clinical investigator in Camden, NJ, revealed significant deficiencies in record-keeping and adherence to investigational plans. Observations included documenting study visits for deceased subjects and failing to properly report adverse events and conduct follow-up visits according to protocol. These issues indicate serious concerns regarding data integrity and patient safety in clinical trials.
Open in Dashboard
ID · 5c29708d-e060-4b5b-a0f6-b062edeb99c2